Emphysema
Pipeline by Development Stage
Drug Modality Breakdown
Competitive Landscape
16 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 40 trials with date data
Clinical Trials (40)
Total enrollment: 4,372 patients across 40 trials
Extension Study of Zemaira® i.v. Administration in Subjects With Emphysema Due to alpha1-proteinase Inhibitor Deficiency.
Effect of Symbicort on Sleep Quality in Patients With Emphysema
Sequential Endoscopic Lung Volume Reduction
Evaluation of Physiologic Parameters to Study the Mechanism of Action of the Lung Volume Reduction Coil in Subjects With Homogeneous Emphysema
International Study Evaluating the Safety and Efficacy of Inhaled, Human, Alpha-1 Antitrypsin (AAT) in Alpha-1 Antitrypsin Deficient Patients With Emphysema
Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)
Prostaglandin Inhibition for Emphysema
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
Pilot Study of the Spiration IBV™ System
Feasibility Study of PneumRx's Lung Volume Reduction Coil (LVRC)
Safety Study of Endobronchial Transplantation of Autologous Mesenchymal Stem Cells (MSCs) in Emphysema Patients
Randomized Comparison of the RePneu Lung Volume Reduction Coil (LVRC) to Standard of Care for the Treatment of Emphysema (RESET Study)
Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction
Zephyr Valve Japan Post-Marketing Surveillance
A Randomized Controlled Trial of InterVapor® in France - The TARGET Trial
Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum
STRIVE Post-Market Registry Study
Mind The Gap - Crossing Borders Study
Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status (CONVERT)
Zephyr Valve Registry (ZEVR)
Study of PneumRx Endobronchial Coil System in Treatment of Subjects With Severe Emphysema
Endoscopic Lung Volume Reduction Coil Treatment in Patients With Chronic Hypercapnic Respiratory Failure
Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System
REACH SVS Control Patient Cross-Over Study
A Prospective Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the OL-BF-001 for Severe Emphysema
Changes in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treatment
Spiration Valve System 9 mm European Post Market Evaluation Study
LVRC IDE Crossover Study (Crossover From IDE Trial CLN0009)
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
Evaluation of the Spiration® Valve System for Emphysema to Improve Lung Function
Sequential Segmental Treatment of Emphysema With Upper Lobe Predominance (STEP-UP) Study
Post Market Observational, Prospective, Multi-center Study
Lung Volume Reduction for Severe Emphysema by Stereotactic Ablative Radiation Therapy
Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study
A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability
Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction
Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema
Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.